(Q44605351)

4 December 2017

Sirolimus for the prevention of in-stent restenosis in a coronary artery (English)

1 reference

4 December 2017

Sirolimus for the Prevention of In-Stent Restenosis in a Coronary Artery (English)

1 reference

17 March 2024

1 reference

Andrew R. Marks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523135

reference URL

17 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

2 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14523135

reference URL

full work available at URL

17 March 2024

http://www.nejm.org/doi/pdf/10.1056/NEJMp038141

1 reference

The New England Journal of Medicine

17 March 2024

published in

1 reference

4 December 2017

349

1 reference

4 December 2017

1307-1309

1 reference

4 December 2017

14

1 reference

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

4 December 2017

1

1 reference

Rapamycin inhibits vascular smooth muscle cell migration

17 March 2024

2

1 reference

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

17 March 2024

3

1 reference

Rapamycin resistance tied to defective regulation of p27Kip1.

17 March 2024

4

1 reference

Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases

17 March 2024

5

1 reference

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

17 March 2024

6

1 reference

17 March 2024

Identifiers

DOI

10.1056/NEJMP038141

1 reference

4 December 2017

1 reference